About: Pamidronate disodium and possible ocular adverse drug reactions

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Pamidronate disodium and possible ocular adverse drug reactions Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 1994

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 1994 (uk) article scientifique publié en 1994 (fr) im August 1994 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 1994 (ast) scientific article published on 01 August 1994 (en)
publication date	wds:Q72113619-3C663149-5490-4950-AEBC-5B9FE92D4F89
publication date	1994-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72113619-C78A65C1-2291-49B4-AC7D-CCE07F00583E
language of work or name	English
cites work	wds:Q72113619-11386656-D91A-4040-B8CC-1647E54F4EAF wds:Q72113619-1EE96483-98F0-4E65-AE6F-B4196FC73962 wds:Q72113619-5539F50E-75CD-4E9A-B2AE-948B2A9BAE32 wds:Q72113619-59D69320-9B83-49A0-9D53-2AD3A991E6AC wds:Q72113619-6C304953-3F2E-41E2-A6F5-6ACF1068AF5A wds:Q72113619-E1A7D300-E270-4255-A3F6-492E21C76B25
cites work	Side-effects of pamidronate The acute-phase response after bisphosphonate administration Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD). APD in Paget's disease of bone. Role of the mononuclear phagocyte system? Bisphosphonates and iritis Systemic sulfonamides as a cause of bilateral, anterior uveitis
author name string	wds:Q72113619-07756EC4-6C77-4FE7-9380-4E54E4B2D939 wds:Q72113619-EA3DA373-742F-41F6-907F-20F02BAEC6BA
author name string	F T Fraunfelder V Macarol
rdfs:label	Pamidronate disodium and possible ocular adverse drug reactions (en) Pamidronate disodium and possible ocular adverse drug reactions (nl)
skos:prefLabel	Pamidronate disodium and possible ocular adverse drug reactions (en) Pamidronate disodium and possible ocular adverse drug reactions (nl)
name	Pamidronate disodium and possible ocular adverse drug reactions (en) Pamidronate disodium and possible ocular adverse drug reactions (nl)
title	wds:Q72113619-3E01DF6C-11DC-48B0-B055-BA166D912BAC
title	Pamidronate disodium and possible ocular adverse drug reactions (en)
page(s)	wds:Q72113619-031990FE-EDF6-4E77-AF23-3253B50A6B8D
page(s)	220-224
instance of	wds:Q72113619-EA891C41-4427-4552-A455-9427406AA9CC
instance of	scholarly article
PubMed ID	wds:Q72113619-6D2D722B-3DA9-4FA3-93A3-3FCA3E2C8C38
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8053468
PubMed ID	8053468
published in	wds:Q72113619-47439318-CE46-4258-AA86-6358E2F95294
published in	American Journal of Ophthalmology
issue	wds:Q72113619-FB80D667-CB62-4237-B102-F8D2C6350761
volume	wds:Q72113619-462E086B-7FE0-4BA4-99D8-F2629CD785CF
issue	2
volume	118
number of pages	wds:Q72113619-C7AB1DE5-29E4-4893-85B1-24AD57BFA89F
number of pages	5 (xsd:decimal)
DOI	wds:Q72113619-EA778E00-56FC-4466-827B-C65905E7D2B7
DOI	http://dx.doi.org/10.1016/S0002-9394(14)72902-2
DOI	10.1016/S0002-9394(14)72902-2
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72113619
is cites work of	Adverse effects of bisphosphonates. A comparative review Ocular adverse effects associated with systemic medications : recognition and management Effect of intravenous pamidronate on bone markers and local bone mineral density in fibrous dysplasia Comparative tolerability of drug therapies for hypercalcaemia of malignancy Use of bisphosphonates for the treatment of stress fractures in athletes Tolerability of intravenous pamidronate for the treatment of osteoporosis and other metabolic osteopathies: A retrospective analysis Paget's disease of bone: clinical, pathogenetic and therapeutic aspects Risedronate in the treatment of Paget's disease of bone: an open label, multicenter study. Safety of long-term bisphosphonate therapy for the management of osteoporosis The role of bisphosphonates as adjuvant therapy for breast cancer Scleritis and other ocular side effects associated with pamidronate disodium Treatment of osteoporosis with bisphosphonates Bisphosphonates Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone Paget's disease of bone Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial Biphosphonates Treatment of osteoporosis with bisphosphonates Expanding role of bisphosphonate therapy in children Guidelines on the management of Paget's disease of bone Drug-induced uveitis. Incidence, prevention and treatment Clinical features and pharmacologic treatment of Paget's disease. Involvement of interleukin-1 in the inflammatory actions of aminobisphosphonates in mice Bisphosphonates in bone diseases Drug-induced uveitis Inhibition of inflammatory actions of aminobisphosphonates by dichloromethylene bisphosphonate, a non-aminobisphosphonate Paget's disease of bone: indications for treatment and goals of therapy Episcleritis secondary to risedronate Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England Diplopia following intravenous administration of pamidronate Drug-induced uveitis Alendronate induced chorioretinitis: The importance of meticulous assessments Therapy insight: scleritis and its relationship to systemic autoimmune disease. Drug-induced uveitis: reporting inflammation while avoiding inflammatory reports Use of zoledronic acid in the treatment of Paget's disease. Bisphosphonates and the treatment of bone disease in the elderly Bisphosphonate treatment of osteoporosis Elevation of histidine decarboxylase activity in the mandible of mice by Prevotella intermedia lipopolysaccharide and its augmentation by an aminobisphosphonate Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria [Zoledronate-induced panuveitis] Safety of drugs used in the treatment of osteoporosis. Marginal structural model to evaluate the association between cumulative osteoporosis medication and infection using claims data. Perspectives for the treatment of osteoporosis Acute uveitis following zoledronic acid infusion Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in England. Diagnosis and treatment of anterior uveitis: optometric management.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software